Speaker illustration

Associate Professor Anastasios Lymperopoulos

Nova Southeastern University, Fort Lauderdale (United States of America)

Dr. Lymperopoulos received an M.Sc. in Medicinal Chemistry followed by Ph.D. in Pharmacology, after graduating from the School of Pharmacy of the Univ. of Patras in Greece. In 2004, he joined the lab of Dr. Walter Koch at Thomas Jefferson University, a former postdoctoral fellow of Nobel laureate Professor Robert Lefkowitz`s. After a successful 5-year-long postdoctoral tenure in Wally`s lab, he moved on to an independent faculty position at Nova Southeastern University in 2009. Since then, he has had several successes, awards and honors, most prominent among which elections as Fellow of the American Heart Association (FAHA) with its Council on Basic Cardiovascular Sciences (BCVS) and as Fellow of the European Society of Cardiology (FESC), as well as a 5-year Scientist Development Grant award from the American Heart Association (AHA). He has also been a finalist for AHA- and ESC-sponsored Young Investigator Awards & currently holds one US-issued patent.

Positive cardiac inotropy by carvedilol via unique beta-arrestin2-dependent SERCA2a stimulation

Event: ESC Congress 2018

Topic: Signal Transduction, Mechanotransduction

Session: Heart Failure: new targets for treatment


Beta-arrestin2 stimulates cardiac function in heart failure via SERCA2a potentiation

Event: ESC CONGRESS 2016

Topic: Growth factors, neurohormones and signal transduction-cardiac

Session: Biological insights in myocardial remodelling


ESC 365 is supported by

logo Novo Nordisk